Pages that link to "Q33992235"

The following pages link to Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance (Q33992235):

Displaying 35 items.

• Prevalence and clinical features of HIV and malaria co-infection in hospitalized adults in Beira, Mozambique (Q21034056) (← links)
• Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review (Q21133667) (← links)
• Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis (Q27009235) (← links)
• Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria? (Q28076750) (← links)
• Antimalarial drug resistance in Africa: key lessons for the future (Q28081457) (← links)
• Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa (Q28084902) (← links)
• Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda (Q28125904) (← links)
• Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012 (Q28125907) (← links)
• Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya (Q28125918) (← links)
• Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts (Q30226671) (← links)
• Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren (Q33728165) (← links)
• A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa (Q34687538) (← links)
• Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial (Q34748630) (← links)
• Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children (Q35607844) (← links)
• Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study (Q35739147) (← links)
• Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi (Q35965190) (← links)
• Malaria and hiv in adults: when the parasite runs into the virus (Q36033898) (← links)
• Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy (Q36051104) (← links)
• Trimester-Specific Population Pharmacokinetics and Other Correlates of Variability in Sulphadoxine-Pyrimethamine Disposition Among Ugandan Pregnant Women (Q36327790) (← links)
• The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa (Q36504556) (← links)
• Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study (Q36517673) (← links)
• Health care resource utilization in untreated HIV-infected children in a pediatric programme, Abidjan, Côte d'Ivoire, 2004-2009. (Q36597730) (← links)
• The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children (Q36743875) (← links)
• Unresolved antiretroviral treatment management issues in HIV-infected children (Q36781481) (← links)
• Optimization of a ligase detection reaction-fluorescent microsphere assay for characterization of resistance-mediating polymorphisms in African samples of Plasmodium falciparum (Q37036298) (← links)
• Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children (Q37096787) (← links)
• Reasons for hospitalization in HIV-infected children in West Africa (Q37723712) (← links)
• Consequences of HIV infection on malaria and therapeutic implications: a systematic review (Q37893776) (← links)
• Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial (Q38860717) (← links)
• Effect of cotrimoxazole prophylaxis on malaria occurrence among HIV-infected adults in West Africa: the MALHIV Study (Q40144262) (← links)
• Burden of asymptomatic malaria, anemia and relationship with cotrimoxazole use and CD4 cell count among HIV1-infected adults living in Gabon, Central Africa (Q46564382) (← links)
• Drug Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo using high-throughput Molecular Inversion Probes. (Q53689124) (← links)
• Antibiotic-resistant and class 1 integrons in people, domestic animals, and wild primates in rural Uganda (Q56909952) (← links)
• The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis (Q64067248) (← links)
• Increased Frequency of Pfdhps A581G Mutation in Plasmodium falciparum Isolates from Gabonese HIV-Infected Individuals (Q92840290) (← links)